Literature DB >> 31533981

Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.

Iris H Chen1, David P Nicolau1, Joseph L Kuti2.   

Abstract

Blood cultures are routinely collected in pairs of aerobic and anaerobic bottles. Artificial sterilization of Gram-negative bacteria in aerobic bottles containing clinically meaningful antibiotic concentrations has previously been observed. This study assessed recovery from anaerobic bottles with and without antibiotic binding resins. We studied the recovery of Escherichia coli and Klebsiella pneumoniae when exposed to meropenem, imipenem, cefepime, cefazolin, levofloxacin, and piperacillin-tazobactam in resin-containing BacT/Alert FN Plus and BD Bactec Plus anaerobic/F bottles as well as resin-free BacT/Alert SN and BD Bactec standard anaerobic bottles. Bottles were inoculated with bacteria and whole blood containing peak, midpoint, or trough concentrations and incubated for up to 120 hours in their respective detection systems. In E. coli resin-containing bottles, recovery was observed in 10/24 (42%), 17/24 (71%), and 18/24 (75%) (P = 0.034) of those exposed to peak, midpoint, and trough concentrations, respectively. In K. pneumoniae resin-containing bottles, recovery was observed in 8/16 (50%), 10/16 (63%), and 10/16 (63%) (P = 0.710), respectively. No growth was detected in bottles containing cefepime regardless of concentration, while recovery was observed in the presence of all concentrations of cefazolin and piperacillin-tazobactam. Recovery in bottles with meropenem and imipenem was more frequently observed in BacT/Alert FN Plus bottles compared with Bactec Plus bottles. Resin-free bottles demonstrated significantly lower recovery than bottles containing binding resin. Clinical concentrations of certain antibiotics can adversely affect detection of E. coli and K. pneumoniae in anaerobic blood culture bottles. Obtaining blood cultures immediately before a dose and utilizing resin-containing anaerobic bottles will maximize the likelihood of recovery.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Escherichia colizzm321990; Klebsiella pneumoniaezzm321990; antimicrobial stewardship; bacteremia; carbapenem; cephalosporin; levofloxacin; piperacillin

Mesh:

Substances:

Year:  2019        PMID: 31533981      PMCID: PMC6879289          DOI: 10.1128/JCM.01344-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Relevance of routine use of the anaerobic blood culture bottle.

Authors:  Patrick Grohs; Jean-Luc Mainardi; Isabelle Podglajen; Xavier Hanras; C Eckert; A Buu-Hoï; E Varon; Laurent Gutmann
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

2.  Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy.

Authors:  Rebecca Zadroga; David N Williams; Richard Gottschall; Kevan Hanson; Vickie Nordberg; Marcia Deike; Mike Kuskowski; Lisa Carlson; David P Nicolau; Christina Sutherland; Glen T Hansen
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

3.  Predominance of Gram-negative bacilli among patients with catheter-related bloodstream infections.

Authors:  E Braun; K Hussein; Y Geffen; G Rabino; Y Bar-Lavie; M Paul
Journal:  Clin Microbiol Infect       Date:  2014-02-20       Impact factor: 8.067

4.  Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens.

Authors:  Miguel Marcos; Alex Soriano; Amaia Iñurrieta; José A Martínez; Alberto Romero; Nazaret Cobos; Cristina Hernández; Manel Almela; Francesc Marco; Josep Mensa
Journal:  J Antimicrob Chemother       Date:  2011-06-10       Impact factor: 5.790

5.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

Authors:  M E A de Kraker; V Jarlier; J C M Monen; O E Heuer; N van de Sande; H Grundmann
Journal:  Clin Microbiol Infect       Date:  2012-10-08       Impact factor: 8.067

6.  Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.

Authors:  Anthony M Nicasio; Robert E Ariano; Sheryl A Zelenitsky; Aryun Kim; Jared L Crandon; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.

Authors:  George L Drusano; Sandra L Preston; Cynthia Fowler; Michael Corrado; Barbara Weisinger; James Kahn
Journal:  J Infect Dis       Date:  2004-04-16       Impact factor: 5.226

8.  Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.

Authors:  Samir G Sakka; Anna K Glauner; Jürgen B Bulitta; Martina Kinzig-Schippers; Wolfgang Pfister; George L Drusano; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

9.  Effects of Clinically Meaningful Concentrations of Antipseudomonal β-Lactams on Time to Detection and Organism Growth in Blood Culture Bottles.

Authors:  Mordechai Grupper; David P Nicolau; Jaber Aslanzadeh; Linda K Tanner; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2017-10-11       Impact factor: 5.948

10.  Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Authors:  T W Felton; J A Roberts; T P Lodise; M Van Guilder; E Boselli; M N Neely; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

View more
  5 in total

1.  Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.

Authors:  Iris H Chen; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  Inactivation of Clinically Frequently Used Antimicrobial Agents By BacT/ALERT FAN Plus and BACTEC Aerobic and Anaerobic Culture Media in Simulated Blood Cultures: First Comparative Evaluation in China Mainland.

Authors:  Xiuyu Xu; Qiang Wei; Zhu Wang; Jie Yan; Huijuan Wang; Yun Xia
Journal:  Infect Drug Resist       Date:  2021-01-19       Impact factor: 4.003

3.  Simulated Pediatric Blood Cultures to Assess the Inactivation of Clinically Relevant Antimicrobial Drug Concentrations in Resin-Containing Bottles.

Authors:  Liliana Giordano; Flora Marzia Liotti; Giulia Menchinelli; Giulia De Angelis; Tiziana D'Inzeo; Grazia Angela Morandotti; Maurizio Sanguinetti; Teresa Spanu; Brunella Posteraro
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

Review 4.  New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care.

Authors:  Anna Maria Peri; Adam Stewart; Anna Hume; Adam Irwin; Patrick N A Harris
Journal:  Curr Infect Dis Rep       Date:  2021-06-16       Impact factor: 3.725

Review 5.  Modern Blood Culture: Management Decisions and Method Options.

Authors:  Mark D Gonzalez; Timothy Chao; Matthew A Pettengill
Journal:  Clin Lab Med       Date:  2020-09-19       Impact factor: 1.935

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.